EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for GNPX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -9.399
March 31, 2026 -14.12
December 31, 2025 -25.33
September 30, 2025 -109.90
June 30, 2025 -186.36
March 31, 2025 -0.2597
December 31, 2024 -466.68
September 30, 2024 -1.233
June 30, 2024 -3.005
March 31, 2024 -4245.71
December 31, 2023 -3.990
September 30, 2023 -5.362
June 30, 2023 -6.141
March 31, 2023 -7.441
December 31, 2022 -5.634
September 30, 2022 -5632.44
June 30, 2022 -5295.84
March 31, 2022 -4879.60
December 31, 2021 -5221.92
September 30, 2021 -2.888
Date Value
June 30, 2021 -3.366
March 31, 2021 -5.700
December 31, 2020 -4.850
September 30, 2020 -2.842
June 30, 2020 -4.948
March 31, 2020 -7.965
December 31, 2019 -5.488
September 30, 2019 -6.002
June 30, 2019 -9.461
March 31, 2019 -5.631
December 31, 2018 -9.094
September 30, 2018 -5.958
June 30, 2018 -17.95
March 31, 2018 -2.365
December 31, 2017 -2495.24
September 30, 2017 -2676.52
June 30, 2017 -4421.12
March 31, 2017 -2.640
December 31, 2016 -3739.56
September 30, 2016 -2694.56

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics